Abstract:Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson’s disease (PD), which is the leading neurodegenerative movement disorder characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). However, whether LRRK2 mutations cause PD and degeneration of DA neurons a toxic gain-of-function or a loss-of-function mechanism is unresolved and has pivotal implications for LRRK2-based PD therapies. In this study, we investigate whether LRRK2 and its functional homologue LRRK1 play an essential, intrinsic role in DA neuron survival through the development of DA neuron-specific conditional double knockout (cDKO) mice. We first generated and characterized floxed and mice and then confirmed that germline deletions of the floxed and alleles result in null mutations, as evidenced by the absence of and mRNA and protein in the respective homozygous deleted mutant mice. We further examined the specificity of Cre-mediated recombination driven by the - ( ) knockin (KI) allele using a GFP reporter line and confirmed that -mediated recombination is restricted to DA neurons in the SNpc. Crossing these validated floxed and mice with KI mice, we then generated DA neuron-restricted cDKO mice and further showed that levels of LRRK1 and LRRK2 are reduced in dissected ventral midbrains of cDKO mice. While DA neuron-restricted cDKO mice of both sexes exhibit normal mortality and body weight, they develop age-dependent loss of DA neurons in the SNpc, as demonstrated by the progressive reduction of DA neurons in the SNpc of cDKO mice at the ages of 20 and 24 months but the unaffected number of DA neurons at the age of 15 months. Moreover, DA neurodegeneration is accompanied with increases of apoptosis and elevated microgliosis in the SNpc as well as decreases of DA terminals in the striatum, and is preceded by impaired motor coordination. Taken together, these findings provide the unequivocal evidence for the importance of LRRK in DA neurons and raise the possibility that LRRK2 mutations may impair its protection of DA neurons, leading to DA neurodegeneration in PD.

Ser 1292 Autophosphorylation is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations

Clinical and Functional Evidence for the Pathogenicity of the LRRK2 P.arg1067gln Variant

LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status

Phosphorylation-dependent 14-3-3 Binding to LRRK2 is Impaired by Common Mutations of Familial Parkinson's Disease.

LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression

LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a/Rab10-dependent manner

Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease

LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons

LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice

Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice is Eliminated by Familial Parkinson's Disease Mutation G2019S

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's disease

Leucine-Rich Repeat Kinases

Cell-autonomous role of leucine-rich repeat kinase in the protection of dopaminergic neuron survival

Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival

LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s disease

In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s

Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission

LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons

Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease

Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant Α-Synuclein